CRP and myocardial infarction: Meanwhile, Pepys et al., 2006 reported the efficacy of 1,6-bis(phosphocholine)-hexane as a specific small-molecule inhibitor of CRP, where injecting rats undergoing acute myocardial infarction abrogated the increase in infarct size and cardiac dysfunction produced by the injection of human CRP [44].